Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary Ischemia

Annals of Human Genetics

Volumn 70, Issue 6, 2006, Pages 705-716

  Suk Danik, J ^a   Chasman, D I ^a   Cannon, C P ^a   Miller, D T ^a   Zee, R Y L ^a   Kozlowski, P ^a   Kwiatkowski, D J ^a   Ridker, P M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Association Study; Atherosclerosis; C Reactive protein; Coronary Ischemia; CRP; Inflammation

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CREATINE KINASE; PRAVASTATIN;

3' UNTRANSLATED REGION; ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; EUROPEAN AMERICAN; EXON; FEMALE; GENETIC VARIABILITY; HEART INFARCTION SIZE; HOMOZYGOTE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ACUTE-PHASE REACTION; AGED; ALLELES; C-REACTIVE PROTEIN; FEMALE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VARIATION (GENETICS);

EID: 33749552613     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2006.00272.x     Document Type: Article

References (38)

1. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
2. Biasucci, L. M., Liuzzo, G., Grillo, R. L., Caligiuri, G., Rebuzzi, A. G., Buffon, A., Summaria, F., Ginnetti, F., Fadda, G. & Maseri, A. (1999) Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99, 855-860.
3. Brull, D. J., Serrano, N., Zito, F., Jones, L., Montgomery, H. E., Rumley, A., Sharma, P., Lowe, G. D., World, M. J., Humphries, S. E. & Hingorani, A. D. (2003) Human CRP gene polymorphism influences CRP levels: Implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23, 2063-2069.
4. Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A. & Skene, A. M. (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350, 1495-1504.
5. Carlson, C. S., Aldred, S. F., Lee, P. K., Tracy, R. P., Schwartz, S. M., Rieder, M., Liu, K., Williams, O. D., Iribarren, C., Lewis, E. C., Fornage, M., Boerwinkle, E., Gross, M., Jaquish, C., Nickerson, D. A., Myers, R. M., Siscovick, D. S. & Reiner, A. P. (2005) Polymorphisms within the C-Reactive Protein (CRP) Promoter Region Are Associated with Plasma CRP Levels. Am J Hum Genet 77, 64-77.
6. Chen, J., Zhao, J., Huang, J., Su, S., Qiang, B. & Gu, D. (2005) -717A > G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: The Beijing atherosclerosis study. J Mol Med 83, 72-78.
7. D'Aiuto, F., Casas, J. P., Shah, T., Humphries, S. E., Hingorani, A. D. & Tonetti, M. S. (2005) C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 179, 413-417.
8. Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D., Pepys, M. B. & Gudnason, V. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350, 1387-1397.
9. Haverkate, F., Thompson, S. G., Pyke, S. D., Gallimore, J. R. & Pepys, M. B. (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349, 462-466.
10. James, S. K., Armstrong, P., Barnathan, E., Califf, R., Lindahl, B., Siegbahn, A., Simoons, M. L., Topol, E. J., Venge, P. & Wallentin, L. (2003) Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: A GUSTO-IV substudy. J Am Coll Cardiol 41, 916-924.
11. Koenig, W., Sund, M., Frohlich, M., Fischer, H. G., Lowel, H., Doring, A., Hutchinson, W. L. & Pepys, M. B. (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99, 237-242.
12. Kovacs, A., Green, F., Hansson, L. O., Lundman, P., Samnegard, A., Boquist, S., Ericsson, C. G., Watkins, H., Hamsten, A. & Tornvall, P. (2005) A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 178, 193-198.
13. Lei, K. J., Liu, T., Zon, G., Soravia, E., Liu, T. Y. & Goldman, N. D. (1985) Genomic DNA sequence for human C-reactive protein. J Biol Chem 260, 13377-13383.
14. Leushner, J. & Chiu, N. H. (2000) Automated mass spectrometry: A revolutionary technology for clinical diagnostics. Mol Diagn 5, 341-348.
15. Lindahl, B., Toss, H., Siegbahn, A., Venge, P. & Wallentin, L. (2000) Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 343, 1139-1147.
16. Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B. & Maseri, A. (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331, 417-424.
17. Livak, K. J., Flood, S. J., Marmaro, J., Giusti, W. & Deetz, K. (1995) Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 4, 357-362.
18. MacGregor, A. J., Gallimore, J. R., Spector, T. D. & Pepys, M. B. (2004) Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: A comparison of monozygotic and dizygotic twins. Clin Chem 50, 130-134.
19. Miller, D. T., Zee, R. Y., Suk Danik, J., Kozlowski, P., D. I. C., Lazarus, R., Cook, N. R., Ridker, P. M. & Kwiatkowski, D. J. (2005) Association of common CRP gene variants with CRP levels and cardiovascular events. Annals of Human Genetics 69, 623-638.
20. Morrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P. & Braunwald, E. (1998) C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 31, 1460-1465.
21. Pai, J. K., Pischon, T., Ma, J., Manson, J. E., Hankinson, S. E., Joshipura, K., Curhan, G. C., Rifai, N., Cannuscio, C. C., Stampfer, M. J. & Rimm, E. B. (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351, 2599-2610.
22. Pankow, J. S., Folsom, A. R., Cushman, M., Borecki, I. B., Hopkins, P. N., Eckfeldt, J. H. & Tracy, R. P. (2001) Familial and genetic determinants of systemic markers of inflammation: The NHLBI family heart study. Atherosclerosis 154, 681-689.
23. Retterstol, L., Eikvar, L. & Berg, K. (2003) A twin study of C-Reactive Protein compared to other risk factors for coronary heart disease. Atherosclerosis 169, 279-282.
24. Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., Braunwald, E. & the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators (2005a) C-Reactive Protein Levels and Outcomes after Statin Therapy. N Engl J Med 352, 20-28.
25. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P. & Hennekens, C. H. (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336, 973-979.
26. Ridker, P. M., Morrow, D. A., Rose, L. M., Rifai, N., Cannon, C. P. & Braunwald, E. (2005b) Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: An analysis of the PROVE-IT TIMI-22 trial. J Am Coll Cardiol 45, 1644-1648.
27. Ridker, P. M., Rifai, N., Rose, L., Buring, J. E. & Cook, N. R. (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347, 1557-1565.
28. Russell, A. I., Cunninghame Graham, D. S., Shepherd, C., Roberton, C. A., Whittaker, J., Meeks, J., Powell, R. J., Isenberg, D. A., Walport, M. J. & Vyse, T. J. (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13, 137-147.
29. Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M. & Poland, G. A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70, 425-434.
30. SeattleSNPs, NHLBI Program for Genomic Applications, Seattle, WA (URL: http://pga.gs.washington.edu) [accessed Jan 2005].
31. Suk, H. J., Ridker, P. M., Cook, N. R. & Zee, R. Y. (2005) Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178, 139-145.
32. Szalai, A. J., Alarcon, G. S., Calvo-Alen, J., Toloza, S. M., McCrory, M. A., Edberg, J. C., McGwin, G., Jr., Bastian, H. M., Fessler, B. J., Vila, L. M., Kimberly, R. P. & Reveille, J. D. (2005) Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA): Association between C-reactive protein (CRP) gene polymorphisms and vascular events. Rheumatology 44, 864-868.
33. Szalai, A. J., Wu, J., Lange, E. M., McCrory, M. A., Langefeld, C. D., Williams, A., Zakharkin, O., George, V., Allison, D. B., Cooper, G. S., Xie, F., Fan, Z., Edberg, C. & Kimberly, R. P. (2005) Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med 83, 440-447.
34. Thompson, S. G., Kienast, J., Pyke, S. D., Haverkate, F. & van de Loo, J. C. (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 332, 635-641.
35. Williams, S. M., Meadows, C. A. & Lyon, E. (2002) Automated DNA extraction for real-time PCR. Clin Chem 48, 1629-1630.
36. Wolford, J. K., Gruber, J. D., Ossowski, V. M., Vozarova, B., Antonio Tataranni, P., Bogardus, C. & Hanson, R. L. (2003) A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metab 78, 136-144.
37. Zebrack, J. S., Anderson, J. L., Maycock, C. A., Horne, B. D., Bair, T. L. & Muhlestein, J. B. (2002) Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol 89, 145-149.
38. Zee, R. Y. & Ridker, P. M. (2002) Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162, 217-219.